BAY3018250 Dose 1

DRUG2 trials

Sponsors

Bayer

Conditions

Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers

Phase 1

A Study to Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

CompletedNCT06562985

BayerAcute Venous and Arterial Thrombotic and Thromboembolic Events, Healthy Volunteers

Start: 2024-09-18End: 2025-01-06Updated: 2025-02-06

A Study to Learn How Safe BAY3018250 is, How it Moves Into, Through and Out of the Body, and How it Affects the Body in Healthy Chinese Participants

CompletedNCT06619483

BayerAcute Venous and Arterial Thrombotic and Thromboembolic Events, Healthy Volunteers

Start: 2024-10-10End: 2025-01-24Updated: 2025-02-10